CelLBxHealth Tightens Costs and Reshapes Strategy as 2025 Revenues Miss Target

ANGLE plc ( (GB:CLBX) ) just unveiled an announcement.

CelLBxHealth reported preliminary unaudited 2025 revenues of about £1.4 million, slightly below expectations after roughly £0.2 million of anticipated sales slipped into the first quarter of 2026, while year-end cash stood at £7.3 million, giving the group a solid financial base. To streamline operations and cut costs, the company has delisted from the OTCQX Market in favour of the lower-cost Pink Limited Market, is consolidating its Guildford operations into a single facility, and implementing headcount and restructuring measures expected to generate annualised savings of approximately £5.9 million, as it pursues a revised commercial strategy underpinned by a qualified 2026/27 sales pipeline of about £12.6 million (risk-weighted £4.5 million).

The most recent analyst rating on (GB:CLBX) stock is a Sell with a £0.95 price target. To see the full list of analyst forecasts on ANGLE plc stock, see the GB:CLBX Stock Forecast page.

Spark’s Take on GB:CLBX Stock

According to Spark, TipRanks’ AI Analyst, GB:CLBX is a Neutral.

The overall stock score reflects significant financial challenges and bearish technical indicators, which are the most impactful factors. While recent corporate events and earnings call achievements provide some positive outlook, the financial and valuation concerns weigh heavily on the score.

To see Spark’s full report on GB:CLBX stock, click here.

More about ANGLE plc

CelLBxHealth plc is a precision circulating tumour cell (CTC) intelligence company that develops innovative CTC-based solutions for research, drug development and clinical oncology. Its patent-protected Parsortix platform isolates tumour cells from blood for downstream imaging, proteomic and genomic analysis, with commercial activities focused on product sales, laboratory services for clinical trials and assay development, and lab-developed tests delivered from its GCLP-compliant UK laboratory.

Average Trading Volume: 3,262,085

Technical Sentiment Signal: Sell

Current Market Cap: £11.36M

See more insights into CLBX stock on TipRanks’ Stock Analysis page.